Name: OBIO Balance Sheet - Orchestra Biomed Holdings. Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

OBIO - Orchestra Biomed Holdings. Inc.

USD | NASDAQ | Healthcare

OBIO Balance Sheet - Orchestra Biomed Holdings. Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Cash And Short Term Investments
Cash And Equivalents	34.7	22.3	30.6	19.8	1.8	2.0
Restricted Cash	-	-	-	0.2	1.8	2.0
Short Term Investments	71.8	44.6	57.0	63.9	-	-
Cash And Short Term Investments	106.5	66.8	87.5	83.7	1.8	2.0
Receivables
Accounts Receivable	0.1	0.1	0.1	0.1	-	-
Current Assets
Inventory	0.3	0.2	0.1	0.3	-	-
Prepaid Expenses	1.0	2.1	1.3	0.5	0.0	0.1
Other Current Assets
Non-Current Assets
Property, Plant & Equipment Gross	3.3	2.7	2.3	2.3	-	-
Accumulated Depreciation	1.6	1.3	1.0	0.8	-	-
Current Liabilities
Accounts Payable	6.1	5.1	2.9	4.0	0.0	0.0
Short Term Debt	-	-	-	-	-	-
Deferred Revenue Current
Non-Current Liabilities
Long Term Debt	15.0	15.0	-	-	-	-
Operating Lease Liabilities Non-Current	0.9	1.7	1.0	1.7	-	-
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0
Additional Paid In Capital	416.1	342.8	316.9	252.3	-	5.2
Retained Earnings
Supplementary Data
Total Debt	15.0	15.0	-	-	-	-
Net debt	(91.5)	(51.8)	-	-	-	-
Working Capital

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20
Cash And Short Term Investments
Cash And Equivalents	28.4	34.7	42.0	18.7	18.3	22.3	25.6	23.7	23.3	30.6	19.1	16.4	18.7	19.8	0.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Non-Current Liabilities
Long Term Debt	15.0	-	15.0	15.0	15.0	-	-	-	-	-	10.0	10.0	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.7	0.9	1.1	1.3	1.5	1.7	1.4	1.1	1.2	1.0	1.1	1.3	1.5	1.7	-	-
Deferred Revenue Non-Current	-	-	8.7	9.6	10.8	11.0	11.4	12.7	13.9	14.9	13.8	13.5	13.2	13.1	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	0.4	0.3	0.2	0.2	0.1	0.0	-	-	-	-	0.3	0.2	0.2	0.2	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	49.7	51.5	61.1	42.5	42.2	43.2	29.1	28.3	25.4	27.2	36.7	36.4	36.5	43.0	7.0	6.7

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	424.5	416.1	412.5	348.3	345.4	342.8	339.8	322.4	319.5	316.9	315.8	312.3	310.5	252.3	-	-	-
Retained Earnings	(383.3)	(362.6)	(368.8)	(348.0)	(328.6)	(309.9)	(293.7)	(278.3)	(262.3)	(248.9)	(236.0)	(222.7)	(210.7)	(199.7)	(6.1)	(5.3)	(4.4)
Accumulated Other Comprehensive Income	(0.0)	0.1	0.0	0.0	0.0	0.1	0.1	(0.0)	(0.0)	(0.0)	(0.1)	(0.1)	(0.0)	(0.0)	-	-
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	41.2	53.6	43.7	0.3	16.9	33.0	46.2	44.1	57.2	68.0	79.7	89.4	99.8	52.5	(6.1)	(5.3)	0.1
Total Equity	41.2	53.6	43.7	0.3	16.9	33.0	46.2	44.1	57.2	68.0	79.7	89.4	99.8	52.5	61.4	69.5	0.1	(19.8)

Supplementary Data
Total Debt	15.0	-	15.0	15.0	15.0	-	-	-	-	-	10.0	10.0	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	(79.4)	-	(80.8)	(18.9)	(34.9)	-	-	-	-	-	(98.5)	(107.7)	-	-	-	-	-	-	-
Working Capital	82.5	91.2	77.1	18.8	36.4	53.0	52.3	52.0	66.0	77.9	88.7	107.7	117.8	66.1	(0.6)	0.2	1.2	1.6
Book Value	41.2	53.6	43.7	0.3	16.9	33.0	46.2	44.1	57.2	68.0	79.7	89.4	99.8	52.5	(6.1)	(5.3)	0.1	(19.8)
Tangible Book Value	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-